Filing Flows › Biotricity (BTCY) › R&D spending
Biotricity (BTCY) R&D spending by quarter
Biotricity's R&D spending was $673K in Q1 FY27 (first quarter fiscal 2027), -20% from Q4 FY26. Over the last 7 quarters it ranged from $551K (Q3 FY25) to $842K (Q4 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $673K | -20% | -3% |
| Q4 FY26 | $842K | +35% | +47% |
| Q3 FY26 | $624K | +3% | +13% |
| Q2 FY26 | $603K | -13% | — |
| Q1 FY26 | $696K | +22% | — |
| Q4 FY25 | $573K | +4% | — |
| Q3 FY25 | $551K | — | — |
Q1 FY27 at a glance
Biotricity, Q1 FY27: revenue $4.3M (+10% year over year), operating margin 3.7%, net loss $959K, operating cash flow $507K. The chart follows the revenue to costs, profit and cash.
Questions
What is Biotricity's R&D spending?
Biotricity's R&D spending was $673K in Q1 FY27 (first quarter fiscal 2027), -20% from Q4 FY26.
How has Biotricity's R&D spending changed?
Over the last 7 quarters it ranged from $551K (Q3 FY25) to $842K (Q4 FY26).